Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Neutrophils
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Neutrophils
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Platelet count
|
HOM
|
9f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.0397
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Platelet count
|
HEM
|
f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.199
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Monocytes
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Monocytes
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell hemoglobin concentration
|
HEM
|
f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0589
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
9f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0909
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Eosinophils
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Eosinophils
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Cells (panel B)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Cells (panel B)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25- T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean platelet volume
|
HOM
|
9f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000383
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean platelet volume
|
HEM
|
f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.704
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
9f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.283
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean corpuscular hemoglobin
|
HEM
|
f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.444
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DP T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DP T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25- NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25- NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q3)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q3)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q1)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell volume
|
HEM
|
f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.377
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell volume
|
HOM
|
9f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.537
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hemoglobin
|
HOM
|
9f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.672
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hemoglobin
|
HEM
|
f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.982
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT cells (panel A)
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q2)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / MZB (CD21/35 high)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / MZB (CD21/35 high)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B1B Cells
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B1B Cells
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell count
|
HOM
|
9f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.843
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell count
|
HEM
|
f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.877
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs CD11b Type
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HEM
|
f:9m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
9f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK cells (panel A)
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hematocrit
|
HEM
|
f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.434
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hematocrit
|
HOM
|
9f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.435
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B2B Cells
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B2B Cells
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q3)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q3)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q4)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q4)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / pDCs
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / pDCs
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell distribution width
|
HOM
|
9f:m
|
Linear Mixed Model framework, LME, not including Weight
|
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell distribution width
|
HEM
|
f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.966
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25- T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Cells (panel B)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Subset
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Subset
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q1)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T cells (panel A)
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T cells (panel A)
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B Cells
|
HEM
|
f:1m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B Cells
|
HOM
|
1f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / White blood cell count
|
HOM
|
9f:m
|
Linear Mixed Model framework, LME, not including Weight
|
|
Successful |
Bex2tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / White blood cell count
|
HEM
|
f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0276
|
Successful |